As dozens of states pursue numerous generic drug makers for price-fixing, a pair of prominent lawmakers have complained to the Justice Department about a “lack of enforcement” and asked the agency to accelerate its own investigation into the companies.

In a letter sent to the feds on Wednesday, Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) also asked the Justice Department to probe whether 14 generic drug makers obstructed their own 2014 investigation into “suspicious” price increases for several generic medicines.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • These generic drug manufacturers are telling lawmakers one of the reasons for the price increases are, ” User Fees”. You would think the lawmakers would say, “what are user fees?”. This is what the PBM’s call drug rebates. PCMA says that
    drug rebates are used for preferential placement on drug formularies, and for excluding other manufacturers.
    If a drug manufacturer pays this “drug rebate” (really extortion) they in turn will increase the price of their drug.
    Competition is good for the consumer! Formularies should be set up by saying, the 3 lowest price manufacturers
    will be put on formulary. Get rid of drug rebates and get rid of the PBM’s ! Then watch and see how fast drug prices
    come down and every state that has been fleeced by these PBM’s will save hundreds of millions of dollars.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy